The Preferred Insulin for the Elderly
Apr 24, 2021
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Oluwatayo Ishola, PharmD. Candidate, South College, School of Pharmacy
Long-acting insulins seem to be the best choice for elderly patients diagnosed with type 2 diabetes.
A study published in JAMA Internal Medicine shows that insulin detemir and insulin glargine had a lower risk of hypoglycemia development in the elderly than NPH insulin. Both insulin glargine and insulin detemir are long-acting insulins, whereas NPH insulin is intermediate-acting. The study was conducted with approximately 575,000 participants. The purpose of this study was to determine the probability of hospital visits in elderly patients with type 2 diabetes who were on long-acting insulin versus NPH due to hypoglycemia.
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.